Edition:
United Kingdom

Pharma Mar Signs License Agreement For Aplidin With Pint Pharma International


Monday, 11 Jun 2018 

June 11 (Reuters) - Pharma Mar SA ::SIGNS COMMERCIALIZATION AND DISTRIBUTION LICENSE AGREEMENT FOR APLIDIN WITH PINT PHARMA INTERNATIONAL.SIGNS LICENSE DEAL IN ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLOMBIA, ECUADOR, MEXICO, PARAGUAY, PERU, URUGUAY AND VENEZUELA.PINT TO PAY UNDISCLOSED MILESTONE, ROYALTY PAYMENTS TO THE CO IN EXCHANGE FOR RIGHTS TO REGISTER, COMMERCIALIZE, DISTRIBUTE APLIDIN IN EACH OF THE FORESAID TERRITORIES.TO RETAIN EXCLUSIVE PRODUCTION RIGHTS AND TO SUPPLY FINISHED PRODUCT FOR CLINICAL AND COMMERCIAL USE. 

Company Quote

1.256
0.106 +9.22%
4:28pm GMT